Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 5 Medulloblastoma 3 Colonic Neoplasms 3 Turcot syndrome 2 Triple Negative Breast Neoplasms 2 Rhabdoid Tumor 2 Recurrence 2 Pinealoma 2 Neuroblastoma 2 Ependymoma 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Solid Tumor 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Gemcitabine 56 pembrolizumab 51 Cisplatin 43 Magnetic Resonance Spectroscopy 27 enfortumab vedotin 23 Specimen Handling 22 Nivolumab 22 Cystectomy 18 durvalumab 16 Carboplatin 16 avelumab 14 Mitomycin 14 atezolizumab 13 Docetaxel 13 Cystoscopy 12 Fluorouracil 11 Radiation 9 Transurethral Resection of Bladder 8 Radiotherapy 8 Ipilimumab 8 sacituzumab govitecan 7 Standard of Care 7 Radiosurgery 7 Paclitaxel 7 Immunoglobulin G 7 Disulfides 7 erdafitinib 6 cemiplimab 6 Surveys and Questionnaires 6 Surgical Procedures, Operative 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Celecoxib × 1 year × Clear all

NCT02885974 2025-07-28

BLAST

Baylor College of Medicine

Phase 1 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡